LPL Financial
TTRX

LPL Financial’s Turn Therapeutics TTRX Stock Holding History

LPL Financial’s Portfolio TTRX Stock Details TTRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.6K Buy
13,300
+300
+2% +$1.17K ﹤0.01% 5802
2025
Q4 		$51.2K Buy
+13,000
New +$54.2K ﹤0.01% 5700

Other funds holding TTRX

DI
DDFG Inc Thousand Oaks, California $464M AUM 16.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TS
Tamar Securities Woodland Hills, California $934M AUM 26.74% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
RW
RVW Wealth Los Angeles, California $1.52B AUM 23.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LPL Financial's TTRX Position: Q1 2026 in Review

LPL Financial increased its Turn Therapeutics (TTRX) stake by 2.3% in Q1 2026, buying an estimated $1.17K and bringing the position to 13,300 shares worth $42.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5802.

LPL Financial first reported a position in TTRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $51.2K in Q4 2025. 20 funds tracked by Wall St. Rank hold TTRX as of Q1 2026.

  • LPL Financial held 13,300 shares of Turn Therapeutics worth $42.6K as of Q1 2026.
  • LPL Financial bought 300 Turn Therapeutics shares in Q1 2026, an estimated $1.17K.
  • Turn Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5802 holding.
  • LPL Financial first reported a position in Turn Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • LPL Financial's Turn Therapeutics position peaked at $51.2K in Q4 2025.
  • 20 funds tracked by Wall St. Rank held Turn Therapeutics as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.